Compound Monograph
Amorfrutin C
Amorfrutin C is a doubly prenylated benzoic acid described in 2016 from the roots of the wild licorice Glycyrrhiza foetida. Unlike its siblings it barely activates PPARγ; what it does instead is depolarise mitochondria and kill colon, prostate and breast cancer cells at 8–16 µM. It has never been reported from false indigo bush.
Sources · 1
Where Does It Come From?
Amorfrutin C is a naturally occurring prenylated benzoic acid (amorfrutin class, diprenylated), found in Glycyrrhiza foetida root. It is flagged as moderately toxic.
Concentration
Content by Source
Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.
Amorfrutin C at a Glance
Amorfrutin C is a prenylated benzoic acid of the amorfrutin class, carrying two prenyl groups where amorfrutin A carries one. It was described as a new natural product in 2016, isolated from the roots of the wild licorice Glycyrrhiza foetida in the same study that characterised its biology 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →.
It is the family’s odd member. The amorfrutins are known as selective PPARγ agonists — the dietary molecules that reproduce a glitazone’s metabolic benefit in mice without the fat gain 2Reference 2AnimalAmorfrutins are potent antidiabetic dietary natural products — animal study in miceView study →. Amorfrutin C activates PPAR comparatively weakly 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →. What it does instead is disrupt mitochondria: it depolarises the mitochondrial membrane at an IC50 of 0.6 µM, forces permanent opening of the permeability transition pore, and kills colorectal, prostate and breast cancer cells at IC50 values of 8–16 µM 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →.
The paper that describes it calls it a promising lead for anticancer drug development. Ten years on, that is still all there is: one primary study, one synthesis, and no animal work of any kind.
It Comes From Licorice, Not From Amorpha
This molecule sits in the false indigo bush’s compound list because it belongs to the amorfrutin family, which the shrub gave its name to. The chemistry does not follow the name.
Amorfrutin C was isolated from Glycyrrhiza foetida roots, and every subsequent study of it has used licorice-sourced or synthetic material 1,
There is also a naming trap worth knowing about. In the mass-spectrometry literature on A. fruticosa, 2-carboxy-3,5-dihydroxy-4-geranylbibenzyl is abbreviated “AC” to sit alongside AA and AB for amorfrutins A and B 6Reference 6Neutral Loss Scan - Based Strategy for Integrated Identification of Amorfrutin Derivatives, New Peroxisome Proliferator-Activated Receptor Gamma Agonists, from Amorpha Fruticosa by UPLC-QqQ-MS/MS and UPLC-Q-TOF-MSView study →. That abbreviation is not amorfrutin C, and the two are different molecules with different substitution.
The practical reading: amorfrutin C is a licorice-derived compound of the amorfrutin scaffold, not a false-indigo-bush constituent, and no preparation of either plant is known to deliver it.
What It's Used For
One primary study carries essentially the whole file, and it is a thorough one — cell-cycle analysis, apoptosis markers, mitochondrial function, structure–activity work and synergy testing, all in cell culture 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →.
Amorfrutin C inhibited proliferation in HT-29 and T84 colorectal, PC-3 prostate and MCF7 breast cancer cells with IC50 values of 8–16 µM, and was less potent against primary colon cells — the one selectivity observation on record. In HT-29 cells it produced G0/G1 arrest with matching changes in cell-cycle regulator proteins, then a full apoptotic programme: caspase activation, DNA fragmentation, PARP cleavage, phosphatidylserine externalisation and reactive-oxygen-species formation. The mechanism was traced to mitochondria — membrane depolarisation at IC50 0.6 µM, permanent opening of the permeability transition pore, and a consequent rise in mitochondrial oxygen consumption and extracellular acidification. Structure–activity experiments identified the carboxylic acid and hydroxy substituents as required for the apoptotic effect, and synergy analysis pointed to stimulation of death-receptor signalling 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →.
A later synthetic study evaluated amorfrutins A–D against pancreatic PANC-1 cells 4Reference 4In vitroSynthesis and biological evaluation of cajaninstilbene acid and amorfrutins A-D as cytotoxic agents against human pancreatic carcinoma PANC-1 cells — in vitroView study →.
Gap: cell culture only — no animal model, no xenograft, no pharmacokinetics. A compound that collapses mitochondrial membrane potential at 0.6 µM while needing 8–16 µM to stop proliferation is acting on an organelle every cell has; the reduced potency in primary colon cells is a single comparison, not a therapeutic index.
The amorfrutins are defined by PPARγ agonism, and the family’s headline result — insulin sensitisation in diet-induced obese and db/db mice without fat gain or hepatotoxicity — belongs to that activity 2Reference 2AnimalAmorfrutins are potent antidiabetic dietary natural products — animal study in miceView study →.
Amorfrutin C was assayed in the same framework and showed comparably lower PPAR activation potential than amorfrutin B, which is the finding that redirected attention to its cytotoxicity 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →.
Later work on the G. foetida amorfrutin series confirmed how sharply the scaffold’s receptor preference tracks small structural changes: amorfrutin A was the strongest PPARγ agonist of the set, amorfrutin H selectively hit PPARα, amorfrutin E was dual-acting, and a decarboxylated analogue was cytotoxic instead 7Reference 7In vitroPPARα/γ-Targeting Amorfrutin Phytocannabinoids from Aerial Parts of Glycyrrhiza foetida — in vitroView study →.
Gap: no receptor-binding constant has been published for amorfrutin C specifically, only the relative statement. Nothing in the antidiabetic literature should be attributed to this molecule — it is the family member that does not do that.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| Mitochondrial membrane potential | depolarisation at IC50 0.6 µM | the primary event behind everything below |
| Mitochondrial permeability transition pore | permanent opening; oxygen consumption and extracellular acidification rise | apoptosis induction |
| Intrinsic apoptotic machinery | caspase activation, PARP cleavage, DNA fragmentation, phosphatidylserine externalisation, ROS | cell death in the four tested lines |
| Cell-cycle regulators | G0/G1 arrest with modulated regulator expression in HT-29 cells | antiproliferative activity |
| Death-receptor signalling | stimulated, per synergy analysis | amplification of the apoptotic response |
| PPARγ / PPARα | activated only weakly, unlike amorfrutins A and B | why the family’s metabolic evidence does not carry over |
The decarboxylated analogue of amorfrutin A is also cytotoxic while losing PPAR agonism 7Reference 7In vitroPPARα/γ-Targeting Amorfrutin Phytocannabinoids from Aerial Parts of Glycyrrhiza foetida — in vitroView study → — consistent with the two activities in this family being separable, and with amorfrutin C sitting on the cytotoxic side of that split.
Pharmacokinetics
None. No absorption, distribution, metabolism, half-life or bioavailability data exist for amorfrutin C in any species, and no in-vivo study of any kind has been published.
Clinical Trials
None, and none preceded by animal work.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| — | — | — | In-vitro cytotoxicity and mechanism; synthesis |
Last checked: September 2026.
Isolate vs. Plant Studies
Entirely isolate, with no plant-side evidence at all — and in this case that is not a caveat about transferability but about relevance. The material tested was purified from Glycyrrhiza foetida roots or made synthetically 1,
Prevalence in Nature
Amorfrutin C has been reported from a single source: the roots of Glycyrrhiza foetida, a wild licorice of the Mediterranean and North Africa, where it occurs alongside amorfrutin B 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →. The species’ aerial parts carry a wider amorfrutin series still — six new and six known members were characterised in one 2023 analysis, together with alkyl-type phytocannabinoids 7Reference 7In vitroPPARα/γ-Targeting Amorfrutin Phytocannabinoids from Aerial Parts of Glycyrrhiza foetida — in vitroView study →, and ten amorfrutins from the same plant were available in purified form for an antibacterial screen 8Reference 8In vitroAmorfrutin-A, a membrane-targeting phytochemical active against multidrug-resistant Staphylococcus aureus: In vitro and in vivo activity and mechanism of actionView study →.
No quantitative content figure has been published for amorfrutin C in any tissue, and it has not been detected in the Amorpha material where the family’s quantitative work has been done 5Reference 5Qualitative and quantitative analysis of amorfrutins, novel antidiabetic dietary natural products, by HPLCView study →. Its distribution beyond G. foetida is simply unknown rather than established as absent — few plants have been looked at with a method that would find it.
Discovery & Synthesis
Amorfrutin C entered the literature in 2016 as compound 2 of a two-compound isolation from Glycyrrhiza foetida roots: a structurally related new natural product beside the already-known amorfrutin B, characterised and biologically profiled in the same paper 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →.
Synthesis followed in 2019. A unified route made both amorfrutin A and amorfrutin C from commercially available 3,5-dimethoxybenzaldehyde; the key step for amorfrutin C is a double Claisen rearrangement of a di-O-(1,1-dimethylallyl)resorcinol derivative, which installs both prenyl groups at C3 and C5 in one operation. It took ten steps at 10% overall yield — noticeably harder than the nine steps and 38% that the mono-prenylated amorfrutin A required 3Reference 3Unified total synthesis of amorfrutins A and C via the Claisen rearrangementView study →. A later synthetic campaign prepared amorfrutins A–D for cytotoxicity testing against pancreatic carcinoma cells 4Reference 4In vitroSynthesis and biological evaluation of cajaninstilbene acid and amorfrutins A-D as cytotoxic agents against human pancreatic carcinoma PANC-1 cells — in vitroView study →.
There is no commercial production and no extraction industry. Amorfrutin C is a research chemical.
Patents: not yet researched.
Toxicity & Safety
The flag here reads moderate for a compound with no toxicology at all, on the strength of its measured mechanism.
- Mitochondrial poison at sub-micromolar concentration. Membrane depolarisation at IC50 0.6 µM and permanent permeability-transition-pore opening are effects on an organelle every cell depends on, not a tumour-specific target 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →.
- The cancer-cell data are not a therapeutic index. Reduced potency against primary colon cells is one comparison in one experiment; no normal-tissue panel and no animal study exist 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →.
- No toxicology of any kind. No acute, repeat-dose, genotoxicity, reproductive or developmental study, in any species.
- Not a licorice constituent in the everyday sense. Nothing about this molecule transfers to commercial licorice, which contains no amorfrutins 5Reference 5Qualitative and quantitative analysis of amorfrutins, novel antidiabetic dietary natural products, by HPLCView study →.
Full Safety & Interactions Detail
What is measured. Amorfrutin C depolarises mitochondrial membranes at IC50 0.6 µM, permanently opens the permeability transition pore, raises mitochondrial oxygen consumption and extracellular acidification, and induces caspase-dependent apoptosis with ROS generation in cancer cell lines at 8–16 µM. It was reported as less potent in primary colon cells, which is the only selectivity observation available 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study →.
What is not. There is no in-vivo exposure of any kind — no acute toxicity study, no repeat-dose work, no genotoxicity assay, no reproductive or developmental data, and no pharmacokinetics. Nothing supports a statement about safety in a whole organism, in either direction.
Interactions. No cytochrome-P450, transporter or drug-interaction data exist. The family’s PPAR activity would raise a pharmacodynamic question with glucose-lowering drugs, but amorfrutin C is the weak PPAR member, so even that inference is thin.
Reproductive note. No reproductive or developmental data exist for the isolated molecule.
Dosage
There is no dose, in any sense that applies to a person. Amorfrutin C has been added to cell cultures and to nothing else. The concentrations on record:
| Setting | Form | Figure |
|---|---|---|
| Antiproliferative activity, four cancer lines | Purified compound in culture | IC50 8–16 µM 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study → |
| Mitochondrial membrane depolarisation | Purified compound in culture | IC50 0.6 µM 1Reference 1In vitroAmorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitroView study → |
These are laboratory concentrations, not a personal recommendation, and no plant preparation is known to supply this molecule.
References
- Weidner C, Rousseau M, Micikas RJ, et al. (2016). Amorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria — in vitro. J Nat Prod. https://pubmed.ncbi.nlm.nih.gov/26731300/
- Weidner C, de Groot JC, Prasad A, et al. (2012). Amorfrutins are potent antidiabetic dietary natural products — animal study in mice. Proc Natl Acad Sci U S A. https://pubmed.ncbi.nlm.nih.gov/22509006/
- Fujita T, Kuwahara S, Ogura Y (2019). Unified total synthesis of amorfrutins A and C via the Claisen rearrangement. Biosci Biotechnol Biochem. https://pubmed.ncbi.nlm.nih.gov/31130067/
- Fujita T, Lin J, Kimishima A, et al. (2022). Synthesis and biological evaluation of cajaninstilbene acid and amorfrutins A-D as cytotoxic agents against human pancreatic carcinoma PANC-1 cells — in vitro. Biosci Biotechnol Biochem. https://pubmed.ncbi.nlm.nih.gov/35157035/
- Chen C, Wu Y, Du L (2016). Qualitative and quantitative analysis of amorfrutins, novel antidiabetic dietary natural products, by HPLC. Pharm Biol. https://pubmed.ncbi.nlm.nih.gov/26004584/
- Chen C, Xue Y, Li QM, et al. (2018). Neutral Loss Scan - Based Strategy for Integrated Identification of Amorfrutin Derivatives, New Peroxisome Proliferator-Activated Receptor Gamma Agonists, from Amorpha Fruticosa by UPLC-QqQ-MS/MS and UPLC-Q-TOF-MS. J Am Soc Mass Spectrom. https://pubmed.ncbi.nlm.nih.gov/29404969/
- Serino E, Iannotti FA, Al-Hmadi HB, et al. (2023). PPARα/γ-Targeting Amorfrutin Phytocannabinoids from Aerial Parts of Glycyrrhiza foetida — in vitro. J Nat Prod. https://pubmed.ncbi.nlm.nih.gov/37940359/
- Lucidi M, Imperi F, Turi M, et al. (2026). Amorfrutin-A, a membrane-targeting phytochemical active against multidrug-resistant Staphylococcus aureus: In vitro and in vivo activity and mechanism of action. Phytomedicine. https://pubmed.ncbi.nlm.nih.gov/42235358/
